Stroke‐like episodes in patients with adult‐onset neuronal intranuclear inclusion disease and patients with late‐onset MELAS : A comparative study
Annals of Clinical and Translational Neurology · 2024
DOI: 10.1002/acn3.52219 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Yuzhi Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: MELAS Syndrome, Intranuclear Inclusion Bodies, Neurodegenerative Diseases, Stroke. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Objective
To delineate the characteristics of stroke‐like episodes (SLEs) in patients with adult‐onset neuronal intranuclear inclusion disease (NIID) and to compare these characteristics with those of patients with MELAS.
Methods
Twenty‐three adult‐onset NIID patients who presented with acute or subacute brain disorders and 13 late‐onset MELAS patients were enrolled in the study. Patients with NIID were categorized into the SLEs group and the encephalopathy‐like episodes (ELEs) group according to the associated stroke‐like lesions (SLLs) findings. Clinical characteristics were compared between the SLEs group and the ELEs group among NIID patients and between NIID patients with SLEs and MELAS patients.
Results
Eleven (47.8%) NIID patients who manifested acute or subacute brain disorders had detectable associated SLLs and were categorized into SLEs group. SLEs patients were more likely to report fever, headache, and seizures instead of sleep disorders than ELEs patients. Four (36.4%) NIID patients with SLEs absence of diagnostic or suggestive NIID imaging features. The clinical manifestations, laboratory test results, and neuroimaging and muscle biopsy histological features of NIID patients with SLEs majorly overlapped with those of late‐onset MELAS patients. Older age at the first SLE (OR [95% CI], 1.203 [1.045–1.384]), symptoms of movement disorders on admission (OR [95% CI], 9.625 [1.378–67.246]), and white matter hyperintensity in corpus callosum (OR [95% CI], 16.00 [1.542–166.46]) associated with the NIID diagnosis in patients with SLEs.
Interpretation
NIID patients with SLEs exhibit evident features of mitochondrial disorders. Interventions aimed at mitochondrial dysfunction might be a promising therapeutic approach for treating this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- China National Clinical Research Center for Neurological Disease, Beijing, China.
ORCID-Profile: Yuzhi Shi, Hongfei Tai, Bin Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shi, Y., Dong, G., Pan, H., Tai, H., Zhou, Y., Wang, A., Niu, S., Chen, B., Wang, X., & Zhang, Z. (2024). Stroke‐like episodes in patients with adult‐onset neuronal intranuclear inclusion disease and patients with late‐onset MELAS : A comparative study. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52219
Vancouver
Shi Y, Dong G, Pan H, Tai H, Zhou Y, Wang A, et al. Stroke‐like episodes in patients with adult‐onset neuronal intranuclear inclusion disease and patients with late‐onset MELAS : A comparative study. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52219
BibTeX
@article{Shi2024,
author = {Shi, Yuzhi and Dong, Gehong and Pan, Hua and Tai, Hongfei and Zhou, Yi and Wang, An and Niu, Songtao and Chen, Bin and Wang, Xingao and Zhang, Zaiqiang},
title = {Stroke‐like episodes in patients with adult‐onset neuronal intranuclear inclusion disease and patients with late‐onset MELAS : A comparative study},
journal = {Annals of Clinical and Translational Neurology},
year = {2024},
doi = {10.1002/acn3.52219}
}
EUVIMED